US Stock MarketDetailed Quotes
OCGN Ocugen
- 0.9698
- +0.0612+6.74%
Close Nov 27 16:00 ET
- 0.9700
- +0.0002+0.02%
Post 19:58 ET
282.52MMarket Cap-5104P/E (TTM)
1.0100High0.9270Low4.41MVolume0.9300Open0.9086Pre Close4.29MTurnover1.54%Turnover RatioLossP/E (Static)291.32MShares2.105052wk High6.98P/B278.69MFloat Cap0.360052wk Low--Dividend TTM287.37MShs Float778.1999Historical High--Div YieldTTM9.14%Amplitude0.1700Historical Low0.9720Avg Price1Lot Size
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
Ocugen Stock Forum
Ocugen Announces European Medicines Agency Grants Orphan Medicinal Product Designation for Modifier Gene Therapy Candidate Ocu410St for Treatment of Abca4-Associated Retinopathies Including Stargardt Disease
Ocugen Announces Compelling Preliminary Data for Ocu410—a Single Dose Novel Modifier Gene Therapy to Treat Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration
No comment yet